Titan Biotech has announced its maiden 1:4 bonus issue, with one share to be issued for every four held, subject to shareholder approval. The multibagger stock has gained over 200% in a year and 100% in 2026. Here’s what investors need to know about the bonus issue and eligibility.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.